Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
4.
Pain Med ; 21(7): 1311-1312, 2020 11 07.
Article in English | MEDLINE | ID: covidwho-436651
5.
Pain Med ; 21(7): 1331-1346, 2020 11 07.
Article in English | MEDLINE | ID: covidwho-38311

ABSTRACT

BACKGROUND: It is nearly impossible to overestimate the burden of chronic pain, which is associated with enormous personal and socioeconomic costs. Chronic pain is the leading cause of disability in the world, is associated with multiple psychiatric comorbidities, and has been causally linked to the opioid crisis. Access to pain treatment has been called a fundamental human right by numerous organizations. The current COVID-19 pandemic has strained medical resources, creating a dilemma for physicians charged with the responsibility to limit spread of the contagion and to treat the patients they are entrusted to care for. METHODS: To address these issues, an expert panel was convened that included pain management experts from the military, Veterans Health Administration, and academia. Endorsement from stakeholder societies was sought upon completion of the document within a one-week period. RESULTS: In these guidelines, we provide a framework for pain practitioners and institutions to balance the often-conflicting goals of risk mitigation for health care providers, risk mitigation for patients, conservation of resources, and access to pain management services. Specific issues discussed include general and intervention-specific risk mitigation, patient flow issues and staffing plans, telemedicine options, triaging recommendations, strategies to reduce psychological sequelae in health care providers, and resource utilization. CONCLUSIONS: The COVID-19 public health crisis has strained health care systems, creating a conundrum for patients, pain medicine practitioners, hospital leaders, and regulatory officials. Although this document provides a framework for pain management services, systems-wide and individual decisions must take into account clinical considerations, regional health conditions, government and hospital directives, resource availability, and the welfare of health care providers.


Subject(s)
Analgesics, Opioid/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Chronic Pain/therapy , Coronavirus Infections/epidemiology , Glucocorticoids/therapeutic use , Pain Management/methods , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , Telemedicine , Appointments and Schedules , Betacoronavirus , COVID-19 , Disinfection , Health Services Accessibility , Humans , Injections , Injections, Intra-Articular , Mass Screening , Military Medicine , Pandemics , Personal Protective Equipment , Personnel Staffing and Scheduling , Public Health , SARS-CoV-2 , Societies, Medical , Substance Withdrawal Syndrome/diagnosis , Triage , Trigger Points , United States , United States Department of Veterans Affairs
SELECTION OF CITATIONS
SEARCH DETAIL